Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Tevogen Inc./ 8-K

Current Report · Items 5.02, 9.01 · 8-K

Tevogen Inc.

TVGNNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 10.1 Form of Restricted Stock Award Agreement, dated September 14, 2026, under Tevogen Inc. 2024 Omnibus Incentive Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Filed Sep 16, 2026Accepted Sep 16, 2026, 5:12 PM EDTCIK 1860871Accession 0001493152-26-042952
View company →Permanent SEC source ↗
Share

Company context

Current securities

TVGNNASDAQ · EQUITY · CurrentTVGNWNASDAQ · WARRANT · Current
Historical securities (3)
LGSTNASDAQ · EQUITY · Historical · closed Feb 14, 2024LGSTUNASDAQ · UNIT · Historical · closed Feb 14, 2024LGSTWNASDAQ · WARRANT · Historical · closed Feb 14, 2024

Recent company filings

  1. Other EventsSep 30, 2026
  2. 4 filingSep 15, 2026
  3. Other EventsSep 10, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security HoldersAug 26, 2026
  5. S-8 filingAug 24, 2026

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 9.01Item 9.01 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 10.1 Form of Restricted Stock Award Agreement, dated September 14, 2026, under Tevogen Inc. 2024 Omnibus Incentive Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.